المؤلفون: Julia Roumiantseva, Shamardina Av, Lebedev Vv, Ralf Herold, Alexander Karachunskiy, T Mahortih, Larisa Fechina, Dudkin Sa, A Rumjanzew, A Timakow, Natalia Miakova, Timofeeva Vn, A. A. Maschan, Günter Henze, L Bajdun, S. Varfolomeeva, A von Stackelberg, N Chipsanova

المصدر: Leukemia. 22:1144-1153

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Pediatrics, Randomization, Adolescent, Anthracycline, medicine.medical_treatment, Russia, Internal medicine, Acute lymphocytic leukemia, Antineoplastic Combined Chemotherapy Protocols, medicine, Asparaginase, Humans, Child, Chemotherapy, Hematology, business.industry, Daunorubicin, Palliative Care, Cytarabine, Infant, Newborn, Infant, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Surgery, Radiation therapy, Clinical trial, Methotrexate, Treatment Outcome, Oncology, El Niño, Vincristine, Child, Preschool, Feasibility Studies, Prednisone, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc662f1985237b327a7a268ca86b231f
https://doi.org/10.1038/leu.2008.63

المؤلفون: Karachunskiĭ AI, Miakova NV, Rumiantseva IuV, Timakov AM, Makhortykh TZh, Fechina LG, Shamardina AV, Dudkin SA, Lebedev VV, Varfolomeeva SR, Timofeeva VN, Herold R, Stakelberg A, Henze G, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2007; Vol. 79 (7), pp. 19-26.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Asparaginase/adverse effects ; Asparaginase/economics ; Asparaginase/therapeutic use ; Child ; Child, Preschool ; Cyclophosphamide/adverse effects ; Cyclophosphamide/economics ; Cyclophosphamide/therapeutic use ; Cytarabine/adverse effects ; Cytarabine/economics ; Cytarabine/therapeutic use ; Daunorubicin/adverse effects ; Daunorubicin/economics ; Daunorubicin/therapeutic use ; Female ; Humans ; Male ; Mercaptopurine/adverse effects ; Mercaptopurine/economics ; Mercaptopurine/therapeutic use ; Methotrexate/adverse effects ; Methotrexate/economics ; Methotrexate/therapeutic use ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prednisone/adverse effects ; Prednisone/economics ; Prednisone/therapeutic use ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/economics ; Vincristine/therapeutic use

SCR Protocol: AIEOP acute lymphoblastic leukemia protocol

عنوان ترانسليتريتد: Rezul'taty lecheniia ostrogo limfoblastnogo leĭkoza u deteĭ po protokolu Moskva-Berlin-91 v 1991-2000 gg.

المؤلفون: Miakova NV; Research Institute of Pediatric Hematology and Oncology, Ministry of Health of the RF, Russian Children's Clinical Hospital, Moscow., Hartmann R, Rudneva AE, Trubina NM, Fechina LG, Timakov AM, Shamardina AV, Lebedev VV, Varfolomeeva SR, Dudkin SD, Dyshlevaia ZM, Timofeeva VN, Rumiantsev AG, Henze H, Karachunskiĭ AI

المصدر: Voprosy onkologii [Vopr Onkol] 2002; Vol. 48 (3), pp. 340-6.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Nauchno-issledovatelʹskiĭ institut onkologii im. N.N. Petrova Country of Publication: Russia (Federation) NLM ID: 0413775 Publication Model: Print Cited Medium: Print ISSN: 0507-3758 (Print) Linking ISSN: 05073758 NLM ISO Abbreviation: Vopr Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*, Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antimetabolites, Antineoplastic/administration & dosage ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Phytogenic/administration & dosage ; Asparaginase/administration & dosage ; Child ; Child, Preschool ; Cytarabine/administration & dosage ; Data Interpretation, Statistical ; Daunorubicin/administration & dosage ; Dexamethasone/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Infant ; Male ; Mercaptopurine/administration & dosage ; Methotrexate/administration & dosage ; Moscow ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Remission Induction ; Risk Factors ; Russia ; Survival Analysis ; Time Factors ; Vincristine/administration & dosage

عنوان ترانسليتريتد: Lechenie ostrogo limfoblastnogo leĭkoza u deteĭ po protokolu OLL-BFM-90m v Rossiĭskoĭ Federatsii i Respublike Belarus'.

المؤلفون: Miakova NV; Research Institute of Pediatric Hematology and Oncology, Ministry of Health of the RF, Russian Children's Clinical Hospital, Moscow., Aleĭnikova OV, Hartmann R, Rudneva AE, Trubina NM, Fechina LG, Timakov AM, Shamardina AV, Lebedev VV, Varfolomeeva SIu, Dudkin SD, Dyshlevaia ZM, Timofeeva VN, Rumiantsev AG, Henze H, Karachunskiĭ AI

المصدر: Voprosy onkologii [Vopr Onkol] 2002; Vol. 48 (3), pp. 347-51.

نوع المنشور: Clinical Trial; Comparative Study; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Nauchno-issledovatelʹskiĭ institut onkologii im. N.N. Petrova Country of Publication: Russia (Federation) NLM ID: 0413775 Publication Model: Print Cited Medium: Print ISSN: 0507-3758 (Print) Linking ISSN: 05073758 NLM ISO Abbreviation: Vopr Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antimetabolites, Antineoplastic/administration & dosage ; Chi-Square Distribution ; Child ; Child, Preschool ; Data Interpretation, Statistical ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Leucovorin/administration & dosage ; Male ; Methotrexate/administration & dosage ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Republic of Belarus ; Risk Factors ; Russia ; Sex Factors ; Survival Analysis ; Time Factors